Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
G19603RR
Summary
- GlyTouCan ID
-
G19603RR
- Subsumption Level
- Base composition
- Monoisotopic Mass
- 3085.13
External Links
- GlyConnect composition
3D Structures
- GlycoShape
- G19603RR
Organisms
| Organisms | Evidence |
|---|---|
| Homo sapiens (human) | |
| Severe acute respiratory syndrome coronavirus 2 |
Taxonomic Hierarchy
Core Protein
| UniProt ID | Protein Name | Reference | Source |
|---|---|---|---|
| P01588 | Erythropoietin | ||
| P07911 | Uromodulin | ||
| P0DTC2 | Spike glycoprotein | ||
| P41222 | Prostaglandin-H2 D-isomerase |
Sequence Descriptors
- GlycoCT
-
RES 1b:x-HEX-1:5 2s:n-acetyl 3b:x-HEX-1:5 4s:n-acetyl 5b:x-HEX-1:5 6s:n-acetyl 7b:x-HEX-1:5 8s:n-acetyl 9b:x-HEX-1:5 10s:n-acetyl 11b:x-HEX-1:5 12s:n-acetyl 13b:x-HEX-1:5 14s:n-acetyl 15b:x-HEX-1:5 16s:n-acetyl 17b:x-HEX-1:5 18b:x-HEX-1:5 19b:x-HEX-1:5 20b:x-HEX-1:5 21b:x-HEX-1:5 22b:x-HEX-1:5 23b:x-HEX-1:5 24b:x-HEX-1:5 25b:x-HEX-1:5|6:d LIN 1:1d(2+1)2n 2:3d(2+1)4n 3:5d(2+1)6n 4:7d(2+1)8n 5:9d(2+1)10n 6:11d(2+1)12n 7:13d(2+1)14n 8:15d(2+1)16n
- WURCS
- WURCS=2.0/3,17,16/[axxxxm-1x_1-5][axxxxh-1x_1-5_2*NCC/3=O][axxxxh-1x_1-5]/1-2-2-2-2-2-2-2-2-3-3-3-3-3-3-3-3/a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?
Literature
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 33871970 | Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells | Gstottner C | 2021 Apr 19 |
|
| 30237853 | Distinct urinary glycoprotein signatures in prostate cancer patients | Kawahara R | 2018 Sep 4 |
|
| 10764840 | Unusual N-glycosylation of a recombinant human erythropoietin expressed in a human lymphoblastoid cell line does not alter its biological properties | Cointe D | 2000 May |
|
